Cannabinoids in the world of scientific studies

The nanoliposomal composition of our products has been proven to help manage stress and anxiety, improve sleep quality, and help with dermatological and other problems that the human body may face. This claim is supported by a number of scientific studies found in this database.

Study Database

In the database of studies below, you can filter by diagnoses/subjects or search by keywords or author names.

  • A nanometer lipid emulsion, lipid nano-sphere (LNS®), as a parenteral drug carrier for passive drug targeting

    Junzo Seki

    Autism
    Show
  • A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable ...

    Derick T Wade

    Autism
    Show
  • A Randomized, Double-blind, Placebo-controlled, Parallel-group,

    Peter M Irving

    Autism
    Show
  • A Review of Emulsion, Micro Emulsion, and Nano Emulsion

    Santosh Nemichand Kale1

    Nano
    Show
  • A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple ...

    M Moreno-Martet

    Autism
    Show
  • Acute effect of cannabidiol on the activity of various novel antiepileptic

    Katarzyna Socałaa

    Autism
    Show
  • Appraising the “entourage effect” Antitumor action of a pure cannabinoid

    Sandra Blasco-Benito

    Autism
    Show
  • Biological bases for a possible effect of cannabidiol in Parkinson’s disease. Ferreira-junior et al 2019

    Nilson C. Ferreira-Junior

    Autism
    Show
  • Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

    Sean D. McAllister

    Autism
    Show
  • Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy

    Ashutosh Shrivastava

    Autism
    Show
  • Cannabinoids - A new hope for breast cancer therapy Caffarel et al 2012

    María M. Caffarel

    Autism
    Show
  • Cannabis sativa L. and Nonpsychoactive Cannabinoids_ Their Chemistry and Role against Oxidative Stress

    Federica Pellati

    Autism
    Show
  • Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines

    Ahmed S. Sultan

    Autism
    Show
  • Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

    Ryuichi Murase

    Autism
    Show
  • Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats.

    María Ceprián

    Autism
    Show
  • Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy

    Debopam Samanta

    Autism
    Show
  • Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model

    Dr Afia B. Ali

    Autism
    Show
  • Cannabis for refractory epilepsy in children: A review focusing on CDKL5 Deficiency Disorder

    Tristan Dale

    Autism
    Show
  • Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol

    Jerzy P. Szaflarski

    Autism
    Show
  • Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

    Elizabeth Martina Bebin

    Autism
    Show
  • patent application_ synthentic Transdermal Cannabidiol For The Treatment Of Focal Epilepsy

    Medical Sciences

    Autism
    Show
  • Prospective evaluation of oral cannabis extracts in children with epilepsy

    Kelly G. Knupp

    Autism
    Show
  • Cannabinoid pharmacology and therapy in gut disorders

    J.A. Uranga

    Autism
    Show
  • Cannabis Induces Clinical and Endoscopic Improvement in Moderately Active Ulcerative Colitis

    Timna Naftali

    Autism
    Show
  • Cannabis Induces a Clinical Response in Patients With Crohn’s Disease: A Prospective Placebo-Controlled Study

    Lihi Bar-Lev Schleider

    Autism
    Show
  • Therapeutic Use of Cannabis in Inflammatory Bowel Disease

    Waseem Ahmed

    Autism
    Show
  • Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

    Mohanraj Rajesh

    Autism
    Show
  • Treatment using cannabidiol in a horse with mechanical allodynia

    K. L. Ellis

    Autism
    Show
  • Cannabidiol (CBD) and its analogs: a review of their effects on inflammation

    Sumner Burstein

    Autism
    Show
  • Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation

    Christopher P. Stanley

    Autism
    Show
  • Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation

    Anna Jastrz

    Autism
    Show
  • Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation

    Amir Hossein Norooznezhad

    Autism
    Show
  • Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation

    Y. Avraham

    Autism
    Show
  • Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review

    Jasmine Turna

    Autism
    Show
  • Cannabidiol Protects against Chronic Plus Binge Alcohol Induced Liver Injury by Modulating Neutrophil Infiltration, E Selectin, Inflammation and Oxidative/Nitrative Stress

    Yuping Wang

    Autism
    Show
  • Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy

    Lili Yang

    Autism
    Show
  • Enhanced prevention of progression of non alcoholic fatty liver to steatohepatitis by incorporating pumpkin seed oil in nanoemulsions

    Sahar Youssef Al-Okbi

    Autism
    Show
  • Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes

    Rongrong Jiang

    Autism
    Show
  • Proactive Investors: WeedMD to supply cannabidiol for new research looking at liver disease treatments

    Medical Sciences

    Autism
    Show
  • Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy

    Shuqian Wan

    Autism
    Show
  • Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats

    Amr A. Fouad

    Autism
    Show
  • Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice

    Peer W. F. Karmaus

    Autism
    Show
  • Endocannabinoid receptor CB2R is significantly expressed in aspirin-exacerbated respiratory disease: a pilot study

    Alessia Corrado

    Autism
    Show
  • Striking lung cancer response to selfadministration of cannabidiol: A case report and literature review

    Josep Sulé-Suso

    Autism
    Show
  • Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms

    Gabriela Pandini Silote - EN

    Depression
    Show
  • Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment

    Marika Premoli

    Autism
    Show
  • Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders

    Daniel Friedman

    Autism
    Show
  • The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

    Manoela V. Fogaça

    Autism
    Show
  • Biological bases for a possible effect of cannabidiol in Parkinson’s disease

    Nilson C. Ferreira-Junior

    Autism
    Show
  • Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

    Philip McGuire

    Autism
    Show
  • Cannabidiol (CBD) use in psychiatric disorders: A systematic review

    Stefania Bonaccorso

    Autism
    Show
  • Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials

    Rafael Mariano Bitencourt

    Autism
    Show
  • Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors

    Cristina A.J. Stern

    Autism
    Show
  • Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial

    Febe E. van der Flier1

    Autism
    Show
  • Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders

    Carl Stevenson

    Autism
    Show
  • Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders

    Regimantas Jurkus

    Autism
    Show
  • Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease

    Caroline E Herron

    Autism
    Show
  • Cannabidiol, neuroprotection and neuropsychiatric disorders

    Alline C. Campos

    Autism
    Show
  • Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

    Maria S. Aymericha

    Autism
    Show
  • Cannabis Therapeutics and the Future of Neurology

    Ethan B. Russo

    Autism
    Show
  • Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning

    A.L. Uhernik

    Autism
    Show
  • Lower circulating endocannabinoid levels in children with autism spectrum disorder

    Adi Aran

    Autism
    Show
  • Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

    Sagnik Bhattacharyya

    Autism
    Show
  • Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

    Tibor Stark

    Autism
    Show
  • Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy

    Lihi Bar-Lev Schleider

    Autism
    Show
  • Review of the neurological benefits of phytocannabinoids

    Joseph Maroon

    Autism
    Show
  • The Endocannabinoid System and the Brain

    Raphael Mechoulam

    Autism
    Show
  • The endocannabinoid system in mental disorders: Evidence from human brain studies

    Inés Ibarra-Lecue

    Autism
    Show
  • Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury

    David Fernández-López

    Autism
    Show
  • Emulsion Micro Emulsion and Nano Emulsion: A Review

    Santosh Nemichand Kale

    Nano
    Show
  • Cannabinoid Delivery Systems for Pain and Inflammation Treatment

    Natascia Bruni

    Nano
    Show
  • Formulation of Natural Oil Nano-Emulsions for the Topical Delivery of Clofazimine, Artemisone and Decoquinate

    Cornel Burger

    Nano
    Show
  • Influence of nonionic branched-chain alkyl glycosides on a model nano-emulsion for drug delivery systems

    Noraini Ahmad

    Nano
    Show
  • Pharmaceutical Nano emulsion as a Rational Carrier for Drug Delivery

    Dr. R.B. Saudagar

    Nano
    Show
  • Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration

    Irina Cherniakova

    Nano
    Show
  • Recent Advances in Nanoparticle-Mediated Delivery of Anti-Inflammatory Phytocompounds

    Raffaele Conte

    Nano
    Show
  • The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability

    Dvora Izgelov

    Nano
    Show
  • The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model

    Irina Cherniakov

    Nano
    Show
  • A nanometer lipid emulsion, lipid nano-sphere (LNS®), as a parenteral drug carrier for passive drug targeting

    Junzo Seki

    Autism
    Show
  • Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs

    Ganesan Poovi

    Autism
    Show
  • Monoacyl-phospatidylcholine based drug delivery systems for lipophilic drugs: Nanostructured lipid carriers vs. nano-sized emulsions

    Martin Wolf

    Autism
    Show
  • Pharmaceutical Nano emulsion as a Rational Carrier for Drug Delivery

    Dr. R.B. Saudagar

    Autism
    Show
  • Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury

    Dehao Lia

    Ortopedie
    Show
  • Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts

    Natalya M Kogan

    Ortopedie
    Show
  • Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects

    Amir Kamalia

    Ortopedie
    Show
  • Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration

    João da Silveira

    Ortopedie
    Show
  • A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

    Derick T Wade

    Autism
    Show
  • Cannabis-based medicines for chronic neuropathic pain in adults (Review)

    Mücke M

    Autism
    Show
  • Chronic pain and cannabinoids. Great expectations or a christmas carol

    D. Pascual

    Autism
    Show
  • Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay

    L. Cuñetti

    Autism
    Show
  • Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

    Attila Oláh

    Skin
    Show
  • Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1

    Laura Casares

    Autism
    Show
  • Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury

    Enrico Sangiovanni

    Autism
    Show
  • A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars

    B. Palmieri

    Autism
    Show
  • Self-initiated use of topical cannabidiol oil for epidermolysis bullosa

    Malcolm P. Chelliah BA

    Autism
    Show
  • What’s New in the Management of Acne Vulgaris

    Leon H. Kircik

    Autism
    Show
  • A Sativexlike combination of phytocannabinoids as a diseasemodifying therapy in a viral model of multiple sclerosis

    A Feliú

    Autism
    Show
  • Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice

    Peer W. F. Karmaus

    Autism
    Show
  • Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

    M. Mecha

    Autism
    Show
  • CTNPT 028: Cannabinoids in HIV-infected individuals on effective ART

    Hannah Branch

    Autism
    Show
  • Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals

    Jennifer A. Manuzak

    Autism
    Show
  • High-intensity cannabis use associated with lower plasma HIV-1 RNA viral load among recently-infected people who use injectable drugs

    M-J Milloy, PhD

    Autism
    Show
  • Potential of Cannabidiol for the Treatment of Viral Hepatitis

    Henry I. C. Lowe

    Autism
    Show
  • Cannabidiol (CBD) use in psychiatric disorders

    Stefania Bonaccorso

    Autism
    Show
  • Cannabidiol in Treatment of Autism Spectrum Disorder

    Alexander Muacevic and John R Adler

    Autism
    Show
  • Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis

    Berzenn Urbi

    Autism
    Show
  • Cannabis in Parkinson's Disease - the patient's perspective versus clinical trials: a systematic literature review

    Monika Figura

    Autism
    Show
  • Medical cannabis as an alternative therapeutics for Parkinsons' disease

    Anastasia Bougea

    Autism
    Show
  • Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson's disease: an open-label observational study

    Itay Lotan, Therese A Treves, Yaniv Roditi, Ruth Djaldetti

    Autism
    Show
  • Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy

    Laura Amato, Silvia Minozzi, Zuzana Mitrova, Elena Parmelli, Rosella Saulle, Fabio Cruciani, Simona Vecchi, Marina Davoli

    Autism
    Show
  • Cannabidiol (CBD) in Cancer Management

    Kylie O'Brien

    Autism
    Show
  • Cannabidiol (CBD) as a Promising Anti-Cancer Drug

    Emily S. Seltzer , ORCID,Andrea K. Watters, ORCID,Danny MacKenzie, Jr. , ORCID,Lauren M. Granat 2ORCID andDong Zhang

    Autism
    Show
  • Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

    Camren G. Heider, Sasha A. Itenberg , Jiajia Rao, Hang Ma, ORCID andXian Wu

    Autism
    Show
  • Cannabis, CBD oil and cancer

    Cancer Research UK

    Autism
    Show
  • Daily use of cannabidiol ('CBD') oil may be linked to lung cancer regression

    BMJ - global healthcare knowledge provider

    Autism
    Show
  • Cannabis and Cannabinoids (PDQ®)

    NIC - National Cancer Institute

    Autism
    Show
  • Abstract 3714: The antitumor activity of cannabis sativa and CBD in prostate cancer PC3 cells

    ACCR Journals - Cancer research

    Autism
    Show
  • Cannabis Use in Patients With Cancer: A Clinical Review

    Brooke Worster

    Oncological diseases
    Show
  • Cannabinoids And Skin Wound Care

    Peter Vermeul

    Skin
    Show
  • Cannabidiol as a chemotherapy adjunct in cancertreatment

    By Mikael Sodergren & Nagina Mangal

    Oncological diseases
    Show
  • Opioid and Cannabinoid Systems in Pain: Emerging Molecular Mechanisms and Use in Clinical Practice, Health, and Fitness

    Carmine Secondulfo

    Pain
    Show

Write us,

we will be happy to connect with you




    UNIQUE THERAPEUTICS GLOBAL s.r.o.

    Na Luhách 1559/14
    400 01 Ústí nad Labem
    Czech Republic

    info@uniquetherepeutics.com
    +420 774 668 177

    Our Team

    Radek Hlaváček

    One of the founding members of Unique Therapeutics, a Canadian company based in Ústí nad Labem, the city where Radek lived until he was 19 years old. As an immigrant he moved to Switzerland and later to Canada, where he has lived with his wife since 1991. He started cultivating cannabis and using the flowers and extracts of Cannabis for medical purposes in 2000 after obtaining his MMAR License (Marijuana Medical Access Regulations).

    Ivana Bednářová

    Ivana Bednářová has twenty years of experience in sales, marketing and public relations, having held senior positions in a number of international companies during her career. Within her own marketing and PR agency, she founded and led several successful projects related to healthy lifestyle and international certification of food supplements and food. A graduate of Anglo American University with a degree in Economics, she has three children and her hobbies include sports, travel and gastronomy.

    Liam Duff

    As the Chief Science and Technology Officer at Unique Therapeutics, Liam is responsible for the development, testing, manufacturing and compliance of our manufacturing processes as well as day-to-day operations. Intellectual property and technology are at the core of our company Unique Therapeutics and Liam is responsible for ensuring we are always at the forefront of the most effective ways to deliver cannabinoids into the body and ensuring our quality is the best it can be.

    Ranjit S. Bhardwaj

    Ranjit S. Bhardwaj after studying biomedical sciences in immunology, cancer immunobiology and regenerative medicine has specialized and qualified in cancer immunobiology and regenerative medicine, cellular and molecular pathology. Dr. Ranjit Bhardwaj is active in a network of cannabis physicians and prescribers, is involved in clinical research projects at universities and R&D forums in Germany and abroad, and holds corporate advisory roles in the medical and pharmaceutical industry.

    Jakub Kryšpín

    Jakub Kryšpín is an expert in cannabis treatment. Since 2013 he has been successfully treating with the help of Phoenix Tears. Since 2021, he has continued his work in healing and scientific knowledge in cooperation with our company, focusing primarily on the treatment of oncological, but also neurodegenerative, autoimmune diseases and other diseases that somehow affect the human endocannabinoid system. Jakub has been suffering from multiple sclerosis since 2006 and was once in a wheelchair. He claims that cannabis is the most important herb on planet Earth, given its wide range of uses.

    Ing. Miloš Podolský

    Miloš Podolský became a new member of the Unique Therapeutics Global team in 2024. Miloš's experience in international sales and marketing has become a welcome asset not only for the company. Unique, but also for our international partners. Unique Therapeutics Global has its roots and experience in Canada where the founding members of Unique have been involved since 2012 in the development of cannabis legalization legislation and conditions for cultivation and processing of medical cannabis. This experience and knowledge helps us to establish cooperation with foreign partners who are thinking about legalization and medical cannabis in their country or are only in the beginning. By combining the many years of knowledge of our company and the business experience of Milos Podolski, we are able to offer a wide range of options both in terms of legislation and production. This places Unique Therapeutics Global with its SEED TO SALE program among the world leaders in the cannabis industry. Milos' hobbies include sailing, boating, sports car racing and traveling.

    John Wanyu

    Current research on CBD shows that cannabis could help African nations with the disease sickle cell anemia. Meetings held with Ugandan government officials in October 2024 have provided the impetus and foundation for the preparation of clinical trials to test the efficacy of Unique Therapeutics' liposomal formulations in the treatment of Sickle Cell Disease. Johnny will be our coordinator and representative in Uganda. His role is to prepare the conditions for the clinical trial, conduct the clinical trial in collaboration with the collaborating university hospital and the Ministry of Health. We hope that our data will confirm the efficacy of Unique T products in the treatment, Unique T will ensure the production and distribution of the drug product in Uganda.